Vascular Anomalies Research Group Publications

Publications 2024

1. Carling U, Berger S, Gjønnæss E, Røsok B, Yaqub S, Lassen K, Fretland ÅA, Dorenberg E (2024)
   Transfemoral hepatic vein access in double vein embolization - initial experience and feasibility
   CVIR Endovasc, 7 (1), 64
   DOI 10.1186/s42155-024-00478-y, PubMed 39225967
2. Frič R, Heier I, Züchner M, Gjertsen Ø, Rezai M (2024)
   Cerebrospinal fluid-lymphatic fistula in a child with generalized lymphatic anomaly treated with targeted blood patch - a rare case report and review of the literature
   Childs Nerv Syst, 40 (4), 1301-1305
   DOI 10.1007/s00381-024-06287-x, PubMed 38236406
3. Holm S, Michelsen AE, Schultz NH, Ueland T, Reikvam H, Holme PA, Aukrust P, Halvorsen B (2024)
   Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses - a case report
   Scand J Clin Lab Invest, 84 (6), 425-427
   DOI 10.1080/00365513.2024.2400663, PubMed 39264796
4. Mero IL, Orozco Rodriguez JM, Bjørgo K, Hankin RA, Krupinska E, Kulseth MA, Rossow MA, Knecht W (2024)
   A mild skeletal phenotype with overlapping features of Miller syndrome and functional characterisation of two new variants of human dihydroorotate dehydrogenase
   Heliyon, 10 (19), e38659
   DOI 10.1016/j.heliyon.2024.e38659, PubMed 39430512
5. Revencu N, Eijkelenboom A, Bracquemart C, Alhopuro P, Armstrong J, Baselga E, Cesario C, Dentici ML, Eyries M, Frisk S, Karstensen HG, Gene-Olaciregui N, Kivirikko S, Lavarino C, Mero IL, Michiels R, Pisaneschi E, Schönewolf-Greulich B, Wieland I, Zenker M, Vikkula M (2024)
   Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA
   Orphanet J Rare Dis, 19 (1), 213
   DOI 10.1186/s13023-024-03196-9, PubMed 38778413
6. Revencu N, Eijkelenboom A, Bracquemart C, Alhopuro P, Armstrong J, Baselga E, Cesario C, Dentici ML, Eyries M, Frisk S, Karstensen HG, Gene-Olaciregui N, Kivirikko S, Lavarino C, Mero IL, Michiels R, Pisaneschi E, Schönewolf-Greulich B, Wieland I, Zenker M, Vikkula M (2024)
   Correction to: Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA
   Orphanet J Rare Dis, 19 (1), 369
   DOI 10.1186/s13023-024-03296-6, PubMed 39375751
7. Røed-Undlien H, Schultz NH, Amundsen EK, Wollmann BM, Molden E, Akerkar RR, Bjørnstad JL (2024)
   Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC-MS and anti-Xa assay?
   Int J Lab Hematol, 46 (5), 946-952
   DOI 10.1111/ijlh.14311, PubMed 38808488
8. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2024)
   Corrigendum to < IN-VITRO APIXABAN REMOVAL BY CYTOSORB® WHOLE BLOOD ADSORBER. AN EXPERIMENTAL STUDY.> <[Journal of Cardiothoracic and Vascular Anesthesia 36/6 (2024) 1636 - 1644]>
   J Cardiothorac Vasc Anesth, 38 (7), 1606-1607
   DOI 10.1053/j.jvca.2024.03.039, PubMed 38580477

Publications 2023

1. Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
   DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
   Scand J Immunol, 98 (1), e13274
   DOI 10.1111/sji.13274, PubMed 37676118
2. Misceo D, Senaratne LDS, Mero IL, Sundaram AYM, Bjørnstad PM, Szczałuba K, Gasperowicz P, Kamien B, Nedregaard B, Holmgren A, Strømme P, Frengen E (2023)
   Novel Loss of Function Variants in CENPF Including a Large Intragenic Deletion in Patients with Strømme Syndrome
   Genes (Basel), 14 (11)
   DOI 10.3390/genes14111985, PubMed 38002928
3. Schultz NH, Bechensteen AG, Tjønnfjord EB, Akkök ÇA, Berg MH (2023)
   New interest group for red blood cell disorders
   Tidsskr Nor Laegeforen, 143 (3)
   DOI 10.4045/tidsskr.22.0731, PubMed 36811425
4. Ververi A, Zagaglia S, Menzies L, Baptista J, Caswell R, Baulac S, Ellard S, Lynch S, Genomics England Research Consortium, Jacques TS, Chawla MS, Heier M, Kulseth MA, Mero IL, Våtevik AK, Kraoua I, Ben Rhouma H, Ben Younes T, Miladi Z, Ben Youssef Turki I, Jones WD, Clement E, Eltze C, Mankad K, Merve A et al. (2023)
   Germline homozygous missense DEPDC5 variants cause severe refractory early-onset epilepsy, macrocephaly and bilateral polymicrogyria
   Hum Mol Genet, 32 (4), 580-594
   DOI 10.1093/hmg/ddac225, PubMed 36067010
5. Wiedmann MKH, Steinsvåg IV, Dinh T, Vigeland MD, Larsson PG, Hjorthaug H, Sheng Y, Mero IL, Selmer KK (2023)
   Whole-exome sequencing in moyamoya patients of Northern-European origin identifies gene variants involved in Nitric Oxide metabolism: A pilot study
   Brain Spine, 3, 101745
   DOI 10.1016/j.bas.2023.101745, PubMed 37383439

Publications 2022

1. Absalom NL, Liao VWY, Johannesen KMH, Gardella E, Jacobs J, Lesca G, Gokce-Samar Z, Arzimanoglou A, Zeidler S, Striano P, Meyer P, Benkel-Herrenbrueck I, Mero IL, Rummel J, Chebib M, Møller RS, Ahring PK (2022)
   Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies
   Nat Commun, 13 (1), 1822
   DOI 10.1038/s41467-022-29280-x, PubMed 35383156
2. Berger S, Andersen R, Smaastuen MC, Rosseland LA, Dorenberg E (2022)
   Long-term changes of health-related quality of life in patients with peripheral vascular malformations - a prospective observational study
   J Plast Reconstr Aesthet Surg, 77, 46-53
   DOI 10.1016/j.bjps.2022.10.024, PubMed 36549122
3. Berger S, Bjark TH, Midtvedt K, Andersen R (2022)
   Regression of a venous malformation during angiotensin-converting enzyme inhibitor treatment for hypertension
   J Vasc Surg Cases Innov Tech, 8 (4), 657-659
   DOI 10.1016/j.jvscit.2022.09.004, PubMed 36262918
4. Carling U, Røsok B, Berger S, Fretland ÅA, Dorenberg E (2022)
   Reply to Letter to the Editor: Portal Vein Embolization with Vascular Plug and n-Butyl Cyanoacrylate: Are We There Yet?
   Cardiovasc Intervent Radiol, 45 (10), 1549-1550
   DOI 10.1007/s00270-022-03239-3, PubMed 36008573
5. Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
   Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
   Vaccines (Basel), 10 (8)
   DOI 10.3390/vaccines10081267, PubMed 36016155
6. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2022)
   In Vitro Apixaban Removal By CytoSorb Whole Blood Adsorber: An Experimental Study
   J Cardiothorac Vasc Anesth, 36 (6), 1636-1644
   DOI 10.1053/j.jvca.2022.01.038, PubMed 35272914
7. Schultz NH, Søraas AVL, Sørvoll IH, Akkök ÇA, Vetlesen A, Bhamra JS, Ahlen MT, Holme PA, Aamodt AH, Skagen K, Skattør TH, Skjelland M, Wiedmann MK (2022)
   Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
   J Stroke Cerebrovasc Dis, 32 (1), 106860
   DOI 10.1016/j.jstrokecerebrovasdis.2022.106860, PubMed 36403363
8. Tarasco E, von Krogh AS, Hrdlickova R, Braschler TR, Iwaniec T, Knöbl PN, Hamada E, Pikovsky O, Farese S, Gutwein O, Kessler P, Schultz NH, von Auer C, Windyga J, Friedman K, Hrachovinova I, George JN, Matsumoto M, Schneppenheim R, Lämmle B, Kremer Hovinga JA (2022)
   Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease
   Res Pract Thromb Haemost, 6 (7), e12814
   DOI 10.1002/rth2.12814, PubMed 36284639
9. Tønne E, Due-Tønnessen BJ, Vigeland MD, Amundsen SS, Ribarska T, Åsten PM, Sheng Y, Helseth E, Gilfillan GD, Mero IL, Heimdal KR (2022)
   Whole-exome sequencing in syndromic craniosynostosis increases diagnostic yield and identifies candidate genes in osteogenic signaling pathways
   Am J Med Genet A, 188 (5), 1464-1475
   DOI 10.1002/ajmg.a.62663, PubMed 35080095

Publications 2021

1. Carling U, Røsok B, Berger S, Fretland ÅA, Dorenberg E (2021)
   Portal Vein Embolization Using N-Butyl Cyanoacrylate-Glue: What Impact Does a Central Vascular Plug Have?
   Cardiovasc Intervent Radiol, 45 (4), 450-458
   DOI 10.1007/s00270-021-03014-w, PubMed 34907454
2. Glinton KE, Hurst ACE, Bowling KM, Cristian I, Haynes D, Adstamongkonkul D, Schnappauf O, Beck DB, Brewer C, Parikh AS, Shinde DN, Donaldson A, Brautbar A, Koene S, van Haeringen A, Piton A, Capri Y, Furlan M, Gardella E, Møller RS, van de Beek I, Zuurbier L, Lakeman P, Bayat A, Martinez J et al. (2021)
   Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
   Am J Med Genet A, 185 (5), 1366-1378
   DOI 10.1002/ajmg.a.62102, PubMed 33522091
3. Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
   Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
   Eur Heart J, 42 (39), 4064-4072
   DOI 10.1093/eurheartj/ehab506, PubMed 34405870
4. Jørgensen SF, Buechner J, Myhre AE, Galteland E, Spetalen S, Kulseth MA, Sorte HS, Holla ØL, Lundman E, Alme C, Heier I, Flægstad T, Fløisand Y, Benneche A, Fevang B, Aukrust P, Stray-Pedersen A, Gedde-Dahl T, Nordøy I (2021)
   A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT
   J Clin Immunol, 42 (2), 404-420
   DOI 10.1007/s10875-021-01189-y, PubMed 34893945
5. Schultz NH, Fareed J, Holme PA (2021)
   Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors-An In Vitro Study
   Clin Appl Thromb Hemost, 27, 10760296211021156
   DOI 10.1177/10760296211021156, PubMed 34060371
6. Schultz NH, Glosli H, Bjørnsen S, Holme PA (2021)
   The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study
   Res Pract Thromb Haemost, 5 (5), e12561
   DOI 10.1002/rth2.12561, PubMed 34263107
7. Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA (2021)
   Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
   N Engl J Med, 384 (22), 2124-2130
   DOI 10.1056/NEJMoa2104882, PubMed 33835768
8. Wiedmann M, Skattør T, Stray-Pedersen A, Romundstad L, Antal EA, Marthinsen PB, Sørvoll IH, Leiknes Ernstsen S, Lund CG, Holme PA, Johansen TO, Brunborg C, Aamodt AH, Schultz NH, Skagen K, Skjelland M (2021)
   Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series
   Front Neurol, 12, 721146
   DOI 10.3389/fneur.2021.721146, PubMed 34393988

Publications 2020

1. Tønne E, Due-Tønnessen BJ, Mero IL, Wiig US, Kulseth MA, Vigeland MD, Sheng Y, von der Lippe C, Tveten K, Meling TR, Helseth E, Heimdal KR (2020)
   Benefits of clinical criteria and high-throughput sequencing for diagnosing children with syndromic craniosynostosis
   Eur J Hum Genet, 29 (6), 920-929
   DOI 10.1038/s41431-020-00788-4, PubMed 33288889

Publications 2019

1. Berger S, Andersen R, Dorenberg E, Meyer T, Weiss I, Smaastuen MC, Rosseland LA (2019)
   Quality of life in patients with vascular malformations outside the central nervous system: Comparison with the general Norwegian population
   J Plast Reconstr Aesthet Surg, 72 (12), 1880-1886
   DOI 10.1016/j.bjps.2019.09.024, PubMed 31636028
2. Mandal E, Filip C, Andersson ME, Øgaard B (2019)
   Eighteen-Year Follow-Up of 160 Consecutive Individuals Born With Unilateral Cleft Lip or Cleft Lip and Alveolus Treated by the Oslo Cleft Lip and Palate Team
   Cleft Palate Craniofac J, 56 (7), 853-859
   DOI 10.1177/1055665618820753, PubMed 30686058
3. Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
   The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
   Thromb Res, 177, 154-156
   DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875

Publications 2018

1. Schultz NH, Holme PA, Bjørnsen S, Henriksson CE, Sandset PM, Jacobsen EM (2018)
   The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis
   Platelets, 31 (1), 43-47
   DOI 10.1080/09537104.2018.1557618, PubMed 30569801
2. Schultz NH, Lundblad R, Holme PA (2018)
   Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
   J Med Case Rep, 12 (1), 138
   DOI 10.1186/s13256-018-1660-9, PubMed 29764497

Publications 2017

1. Filip C, Impieri D, Aagenæs I, Breugem C, Høgevold HE, Særvold T, Aukner R, Lima K, Tønseth K, Abrahamsen TG (2017)
   Adults with 22q11.2 deletion syndrome have a different velopharyngeal anatomy with predisposition to velopharyngeal insufficiency
   J Plast Reconstr Aesthet Surg, 71 (4), 524-536
   DOI 10.1016/j.bjps.2017.09.006, PubMed 29032918
2. Mero IL, Mørk HH, Sheng Y, Blomhoff A, Opheim GL, Erichsen A, Vigeland MD, Selmer KK (2017)
   Homozygous KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures
   Hum Mol Genet, 26 (19), 3792-3796
   DOI 10.1093/hmg/ddx263, PubMed 28934391
3. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
   The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
   Thromb J, 15, 6
   DOI 10.1186/s12959-017-0129-1, PubMed 28239301
4. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
   The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro
   Res Pract Thromb Haemost, 1 (1), 49-56
   DOI 10.1002/rth2.12015, PubMed 30046673

Publications 2016

1. Berg E, Haaland ØA, Feragen KB, Filip C, Vindenes HA, Moster D, Lie RT, Sivertsen Å (2016)
   Health Status Among Adults Born With an Oral Cleft in Norway
   JAMA Pediatr, 170 (11), 1063-1070
   DOI 10.1001/jamapediatrics.2016.1925, PubMed 27668670
2. Berg E, Sivertsen Å, Ariansen AM, Filip C, Vindenes HA, Feragen KB, Moster D, Lie RT, Haaland ØA (2016)
   Socio-Economic Status and Reproduction among Adults Born with an Oral Cleft: A Population-Based Cohort Study in Norway
   PLoS One, 11 (9), e0162196
   DOI 10.1371/journal.pone.0162196, PubMed 27631472
3. Breugem CC, Evans KN, Poets CF, Suri S, Picard A, Filip C, Paes EC, Mehendale FV, Saal HM, Basart H, Murthy J, Joosten KF, Speleman L, Collares MV, van den Boogaard MJ, Muradin M, Andersson ME, Kogo M, Farlie PG, Don Griot P, Mossey PA, Slator R, Abadie V, Hong P (2016)
   Best Practices for the Diagnosis and Evaluation of Infants With Robin Sequence: A Clinical Consensus Report
   JAMA Pediatr, 170 (9), 894-902
   DOI 10.1001/jamapediatrics.2016.0796, PubMed 27429161

Publications 2015

1. Filip C, Feragen KB, Lemvik JS, Lindberg N, Andersson EM, Rashidi M, Matzen M, Høgevold HE (2015)
   Multidisciplinary Aspects of 104 Patients With Pierre Robin Sequence
   Cleft Palate Craniofac J, 52 (6), 732-42
   DOI 10.1597/14-161, PubMed 25554857
2. Tønseth KA, Filip C, Hermann R, Vindenes H, Høgevold HE (2015)
   Extraordinary Large Giant Congenital Melanocytic Nevus Treated with Integra Dermal Regeneration Template
   Plast Reconstr Surg Glob Open, 3 (7), e469
   DOI 10.1097/GOX.0000000000000454, PubMed 26301158

Publications 2014

1. Andersson EM, Feragen KB, Mikalsen D, Kaul J, Holla TM, Filip C (2014)
   Bilateral Hypodontia in Adolescents With Pierre Robin Sequence
   Cleft Palate Craniofac J, 52 (4), 452-7
   DOI 10.1597/AAID-JOI-D-11-00190, PubMed 25058123
2. Filip C (2014)
   Response re: 'Autologous fat grafting for the treatment of velopharyngeal insufficiency: state of the art'
   J Plast Reconstr Aesthet Surg, 67 (8), 1155-6
   DOI 10.1016/j.bjps.2014.02.001, PubMed 24581953
3. Filip C (2014)
   Autologous Fat Injection Combined with Palatoplasty and Pharyngoplasty for Velopharyngeal Insufficiency and Cleft Palate: Preliminary Experience
   Otolaryngol Head Neck Surg, 150 (6), 1094
   DOI 10.1177/0194599814529406, PubMed 24890081
4. Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF (2014)
   Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general
   J Neuroimmunol, 274 (1-2), 174-9
   DOI 10.1016/j.jneuroim.2014.06.024, PubMed 25037176
5. van Nunen DP, Filip C, Feragen KJ, van den Boogaard MJ, Breugem CC (2014)
   Reaction to: Persson et al. Educational achievements in Pierre Robin sequence. J Plast Surg Hand Surg 2013;47(1):36-9
   J Plast Surg Hand Surg, 48 (4), 287-8
   DOI 10.3109/2000656X.2014.924956, PubMed 24909823

Publications 2013

1. Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A (2013)
   No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis
   Ann Neurol, 73 (3), 430-2
   DOI 10.1002/ana.23833, PubMed 23444327
2. Filip C, Matzen M, Aukner R, Moe M, Høgevold HE, Åbyholm F, Abrahamsen TG, Tønseth K (2013)
   Superiorly based pharyngeal flap for treatment of velopharyngeal insufficiency in patients with 22q11.2 deletion syndrome
   J Craniofac Surg, 24 (2), 501-4
   DOI 10.1097/SCS.0b013e31827c84f2, PubMed 23524725
3. Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA (2013)
   Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
   Mult Scler, 20 (6), 660-8
   DOI 10.1177/1352458513506503, PubMed 24099750
4. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M et al. (2013)
   Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
   Nat Genet, 45 (11), 1353-60
   DOI 10.1038/ng.2770, PubMed 24076602
5. Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, Kockum I, Oturai AB, Celius EG, Mero IL, Dubois B, Olsson T, Søndergaard HB, Cusi D, Lupoli S, Andreassen BK, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Myhr KM, Guerini FR, PROGEMUS Group, PROGRESSO Group, Comi G, Martinelli-Boneschi F, D'Alfonso S (2013)
   Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients
   PLoS One, 8 (6), e64408
   DOI 10.1371/journal.pone.0064408, PubMed 23785401
6. Maehlen MT, Provan SA, de Rooy DP, van der Helm-van Mil AH, Krabben A, Saxne T, Lindqvist E, Semb AG, Uhlig T, van der Heijde D, Mero IL, Olsen IC, Kvien TK, Lie BA (2013)
   Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis
   PLoS One, 8 (4), e60970
   DOI 10.1371/journal.pone.0060970, PubMed 23613766
7. Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH, International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF (2013)
   Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
   PLoS One, 8 (3), e58352
   DOI 10.1371/journal.pone.0058352, PubMed 23472185

Publications 2012

1. Filip C, Matzen M, Aagenæs I, Aukner R, Kjøll L, Høgevold HE, Tønseth K (2012)
   Autologous fat transplantation to the velopharynx for treating persistent velopharyngeal insufficiency of mild degree secondary to overt or submucous cleft palate
   J Plast Reconstr Aesthet Surg, 66 (3), 337-44
   DOI 10.1016/j.bjps.2012.11.006, PubMed 23254179
2. Harbo HF, Mero IL (2012)
   From genes to characteristics of multiple sclerosis
   Acta Neurol Scand Suppl (195), 76-83
   DOI 10.1111/ane.12027, PubMed 23278661
3. Leikfoss IS, Mero IL, Dahle MK, Lie BA, Harbo HF, Spurkland A, Berge T (2012)
   Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus
   Genes Immun, 14 (1), 62-6
   DOI 10.1038/gene.2012.52, PubMed 23151489
4. Mero IL, Smestad C, Lie BA, Lorentzen ÅR, Sandvik L, Landrø NI, Aarseth JH, Myhr KM, Celius EG, Harbo HF (2012)
   Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course
   J Neuroimmunol, 244 (1-2), 107-10
   DOI 10.1016/j.jneuroim.2012.01.011, PubMed 22341604

Publications 2011

1. Filip C, Matzen M, Aagenæs I, Aukner R, Kjøll L, Høgevold HE, Abyholm F, Tønseth K (2011)
   Speech and magnetic resonance imaging results following autologous fat transplantation to the velopharynx in patients with velopharyngeal insufficiency
   Cleft Palate Craniofac J, 48 (6), 708-16
   DOI 10.1597/09-161, PubMed 21463181
2. Heier I, Søyland E, Krogstad AL, Rodríguez-Gallego C, Nenseter MS, Jahnsen FL (2011)
   Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin
   Br J Dermatol, 165 (4), 792-801
   DOI 10.1111/j.1365-2133.2011.10430.x, PubMed 21623747
3. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B et al. (2011)
   Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
   Nature, 476 (7359), 214-9
   DOI 10.1038/nature10251, PubMed 21833088
4. Søndergaard HB, Sellebjerg F, Hillert J, Olsson T, Kockum I, Lindén M, Mero IL, Myhr KM, Celius EG, Harbo HF, Christensen JR, Börnsen L, Sørensen PS, Oturai AB (2011)
   Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655
   Eur J Hum Genet, 19 (10), 1100-3
   DOI 10.1038/ejhg.2011.88, PubMed 21610746
5. Søyland E, Heier I, Rodríguez-Gallego C, Mollnes TE, Johansen FE, Holven KB, Halvorsen B, Aukrust P, Jahnsen FL, de la Rosa Carrillo D, Krogstad AL, Nenseter MS (2011)
   Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis
   Br J Dermatol, 164 (2), 344-55
   DOI 10.1111/j.1365-2133.2010.10149.x, PubMed 21271993

Publications 2010

1. Heier I, Malmström K, Sajantila A, Lohi J, Mäkelä M, Jahnsen FL (2010)
   Characterisation of bronchus-associated lymphoid tissue and antigen-presenting cells in central airway mucosa of children
   Thorax, 66 (2), 151-6
   DOI 10.1136/thx.2010.149591, PubMed 21163807
2. Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero IL, Gabriel SB, Mirel DB, Hauser SL, Kappos L, Polman C, De Jager PL, Hafler DA et al. (2010)
   Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene
   Am J Hum Genet, 86 (2), 285-91
   DOI 10.1016/j.ajhg.2010.01.017, PubMed 20159113
3. Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF (2010)
   Association to the Glypican-5 gene in multiple sclerosis
   J Neuroimmunol, 226 (1-2), 194-7
   DOI 10.1016/j.jneuroim.2010.07.003, PubMed 20692050
4. Mero IL, Ban M, Lorentzen ÅR, Smestad C, Celius EG, Sæther H, Saeedi H, Viken MK, Skinningsrud B, Undlien DE, Aarseth J, Myhr KM, Granum S, Spurkland A, Sawcer S, Compston A, Lie BA, Harbo HF (2010)
   Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus
   Genes Immun, 12 (3), 191-8
   DOI 10.1038/gene.2010.59, PubMed 21179112

Publications 2009

1. Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF (2009)
   Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis
   Ann Neurol, 65 (6), 658-66
   DOI 10.1002/ana.21695, PubMed 19630074
2. Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, Saarela J, Kemppinen A, Elovaara I, Spurkland A, Dudbridge F, Lie BA, Harbo HF (2009)
   A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis
   Eur J Hum Genet, 18 (4), 502-4
   DOI 10.1038/ejhg.2009.195, PubMed 19888296

Publications 2008

1. Heier I, Hofgaard PO, Brandtzaeg P, Jahnsen FL, Karlsson M (2008)
   Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma
   Clin Exp Immunol, 152 (2), 381-7
   DOI 10.1111/j.1365-2249.2008.03642.x, PubMed 18341610
2. Heier I, Malmström K, Pelkonen AS, Malmberg LP, Kajosaari M, Turpeinen M, Lindahl H, Brandtzaeg P, Jahnsen FL, Mäkelä MJ (2008)
   Bronchial response pattern of antigen presenting cells and regulatory T cells in children less than 2 years of age
   Thorax, 63 (8), 703-9
   DOI 10.1136/thx.2007.082974, PubMed 18250182

Publications 2003

1. Heier I, Knudsen PK, Wathne KO (2003)
   [Infections with atypical mycobacteria in children]
   Tidsskr Nor Laegeforen, 123 (6), 800-2
   PubMed 12693120

Publications 2002

1. Holmström H, Filip C (2002)
   Aponeurotic repair of involutional blepharoptosis
   Scand J Plast Reconstr Surg Hand Surg, 36 (3), 160-5
   DOI 10.1080/028443102753718041, PubMed 12141204